Beta program

Transform access to clinical trials with our matching API

Empower your institution with precision trial matching. Designed for seamless integration with existing EHR systems and clinical workflows, our matching API uses GenAI to automatically pre-screen patient records for potential trial eligibility—opening the door to treatment options in the patient’s care journey

 

 

Delivering patient pre-screening at scale

With over 500,000 clinical trials registered globally and more than 8,000 drugs in development, navigating the trial landscape can be overwhelming and time consuming for healthcare providers—leaving eligible patients unaware of potential treatment options.

The myTomorrows matching API transforms the way healthcare organizations connect patients with clinical trials. With 98% accuracy, it automates pre-screening at superhuman precision, all while ensuring enterprise-grade compliance (ISO27001, SOC II, GDPR, and HIPAA) and comprehensive coverage of key registries ClinicalTrials.gov, EudraCT, and ISRCTN.

See how it works



Key features

High-volume screening

Effortlessly screen thousands of patients at scale, identifying new treatment opportunities and integrating them directly into care plans.

Seamless integration

Embed matching API into your existing EHR system and clinical workflow infrastructure.

Multi-format processing

Process a wide range of healthcare data formats for comprehensive and accurate eligibility assessment.

How it works

Connect

1. Seamless API integration

Integrate into your existing EHR, patient registry, or internal systems. The API complies with ISO27001, SOC II, GDPR, and HIPAA standards, with the option for EU hosting to meet your data security requirements.

Screen

2. Automated high-volume screening

Index active clinical trials across 200+ countries by sourcing real-time data from trusted registries such as ClinicalTrials.gov, EudraCT, and ISRCTN.

Match

3. Precision trial matching

Receive highly accurate trial matches (98% accuracy) tailored to each patient’s medical profile, empowering you to incorporate treatment options into your care plans.

We’ve helped

14.000+

patients access treatment.

With a community of

2.200+

healthcare professionals.

Across

125+

countries.


Frequently Asked Questions

Who is myTomorrows?

myTomorrows is a global healthtech company dedicated to breaking down barriers for patients seeking treatment options. To make this a reality, the company has built a unique and powerful proprietary technology that conducts a comprehensive and accurate search of clinical trials registries worldwide, efficiently connecting patients, physicians, trial sites and BioPharma to simplify and accelerate access to drugs in development. Headquartered in Amsterdam with an office in New York City, myTomorrows has helped more than 14,000 patients and 2,200 physicians across 200+ sites in over 125 countries.

Who can benefit from this solution?

The myTomorrows matching API offers unique benefits to healthcare providers, clinical research organizations, and healthtech companies. Whether you’re looking to streamline trial recruitment, expand treatment options for patients, or enhance clinical workflows, our solution helps identify eligible patients with unmatched accuracy and efficiency. By integrating seamlessly into existing systems, it empowers institutions to offer timely and relevant clinical trial opportunities as part of standard care.

What about patient privacy?

Patient privacy is our top priority. The API is built with enterprise-grade security and fully complies with ISO27001, SOC II, GDPR, and HIPAA regulations, ensuring that all patient data is handled with the highest levels of confidentiality and protection. Additionally, healthcare institutions retain full control over their data, with deployment options that include EU-based hosting for enhanced regulatory compliance. 

Reserve your spot

Be among the first to experience this transformative solution with dedicated support from our technical team. Submit your interest today as this program will close soon.

Please enable JavaScript in your browser to complete this form.
Marketing consent

Thank you for contacting myTomorrows! Our team will be in touch soon.

Michel van Harten CEO myTomorrows

"At myTomorrows, we're purpose-driven, committed to serving and connecting all stakeholders across the care continuum and pre-approval journey. Built for pre-screening at scale, our technology will unlock immense efficiency gains while ensuring more qualified patients gain timely access to trials."

Michel van Harten, MD - CEO myTomorrows